Targeting Cx43 may offer new therapeutic directions for preventing and treating DCM, providing a theoretical basis for understanding cardiac disease mechanisms and progression, though further research is needed to clarify specific mechanisms. This evidence concerns the gene GJA1 and heart disorder.